Pediatric Sepsis and Precision Therapeutics
Projects within the Kaplan lab seek to investigate critical mechanisms in pediatric sepsis and provide precision therapeutics to improve outcomes in critically ill patients.
Projects within the Kaplan lab seek to investigate critical mechanisms in pediatric sepsis and provide precision therapeutics to improve outcomes in critically ill patients.
Investigating the molecular mechanisms by which STAT3 signaling contributes to adipose tissue browning and inflammation in pediatric sepsis.
This work is supported by an NIH R01GM126551 award.
Developing pharmacometric models to optimize beta-lactam antibiotic dosing in pediatric patients, aiming to improve therapeutic outcomes and reduce resistance.
This work is supported by NIGMS R35 Maximizing Investigator Research Award to Dr. Tang Girdwood.
In collaboration with Dr. Basilia Zingarelli, we are establishing a biobank of extracellular vesicles from pediatric sepsis patients to study their role in disease progression and potential as biomarkers.
This work is supported by NIH R33GM151734.